Cargando…

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma

p53 and Bcl-2 are two important factors related to apoptosis and tumorigenesis. In this study, a series of 52 cases of pancreatic carcinoma (PC) were investigated using an immunohistochemical assay to determine whether altered expression of Bcl-2 and p53 has an impact on the progression of this mali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Y-X, Watanabe, H, Ohtsubo, K, Yamaguchi, Y, Ha, A, Motoo, Y, Okai, T, Sawabu, N
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363052/ https://www.ncbi.nlm.nih.gov/pubmed/10362119 http://dx.doi.org/10.1038/sj.bjc.6690466

Ejemplares similares

Detection of K‐ras Point Mutations at Codon 12 in Pancreatic Juice for the Diagnosis of Pancreatic Cancer by Hybridization Protection Assay: A Simple Method for the Determination of the Types of Point Mutations
por: Watanabe, Hiroyuki, et al.
Publicado: (1996)

Identification of K‐ras Oncogene Mutations in the Pure Pancreatic Juice of Patients with Ductal Pancreatic Cancers
por: Watanabe, Hiroyuki, et al.
Publicado: (1993)

Reduced p21(WAF1/CIP1)protein expression is predominantly related to altered p53 in hepatocellular carcinomas
por: Shi, Y-Z, et al.
Publicado: (2000)

The expression of p73 is increased in lung cancer, independent of p53 gene alteration
por: Tokuchi, Y, et al.
Publicado: (1999)

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor
por: Tian, X X, et al.
Publicado: (1999)

p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis
por: Yasuda, M, et al.
Publicado: (2000)

Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as prognostic marker
por: Chia, S-J, et al.
Publicado: (2000)

Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations
por: Rashid, A, et al.
Publicado: (1999)

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status
por: Mirjolet, J-F, et al.
Publicado: (2000)

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
por: Beale, P J, et al.
Publicado: (2000)

Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia
por: Zhu, Y-M, et al.
Publicado: (1999)

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
por: Borner, M M, et al.
Publicado: (1999)

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome
por: Mishina, T, et al.
Publicado: (1999)

Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours
por: Nawa, G, et al.
Publicado: (1999)

Mitigation of apoptosis-mediated neurotoxicity induced by silver nanoparticles via rutaceae nutraceuticals: P53 activation and Bax/Bcl-2 regulation
por: Abdel-Megeed, Rehab M., et al.
Publicado: (2022)

Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers
por: Kitamura, S, et al.
Publicado: (2000)

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
por: Zhai, Y-L, et al.
Publicado: (1999)

Prognostic value of p53 protein expression for patients with gastric cancer – a multivariate analysis
por: Maehara, Y, et al.
Publicado: (1999)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

Topographic expression of p21WAF1/SDI1/CIP1, bcl2, and p53 is altered at the early stage of colorectal carcinogenesis.
por: Cho, J. H., et al.
Publicado: (2000)

Alcohol consumption and cigarette smoking in relation to high frequency of p53 protein accumulation in oesophageal squamous cell carcinoma in the Japanese
por: Saeki, H, et al.
Publicado: (2000)

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
por: Leung, W K, et al.
Publicado: (2001)

Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas
por: Yagi, O K, et al.
Publicado: (1999)

Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma
por: Kuroki, T, et al.
Publicado: (1999)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells
por: Akeshima, R, et al.
Publicado: (2001)

Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations
por: Nakagawa, S, et al.
Publicado: (1999)

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
por: Creaney, J, et al.
Publicado: (2001)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells
por: Pruschy, M, et al.
Publicado: (1999)

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
por: Tanaka, F, et al.
Publicado: (2001)

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001)

Mutation analysis of P73 and TP53 in Merkel cell carcinoma
por: Gele, M Van, et al.
Publicado: (2000)

Genetic alterations on chromosome 17p associated with response to radiotherapy in bulky cervical cancer
por: Harima, Y, et al.
Publicado: (1999)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
por: Wei, Hudie, et al.
Publicado: (2023)

Bcl10 is not a target for frequent mutation in human carcinomas
por: Lambers, A R, et al.
Publicado: (1999)

Alteration of p53 Clonality Accompanying Colorectal Cancer Progression
por: Kuwabara, Akifumi, et al.
Publicado: (1998)

TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe
por: Tanière, P, et al.
Publicado: (2001)

Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7
por: Leung, L K, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_rhqsvguckigdq24q2bj4bou7et